Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Total 13F shares
-
976,580
-
Share change
-
-197,694
-
Total reported value
-
$10,615,889
-
Price per share
-
$10.90
-
Number of holders
-
12
-
Value change
-
-$2,060,042
-
Number of buys
-
4
-
Number of sells
-
9
Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q2 2023
As of 30 Jun 2023 CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 976,580 shares of stock of the company.
Largest 10 holders included CLEAR STREET LLC, METEORA CAPITAL, LLC, Mint Tower Capital Management B.V., Polar Asset Management Partners Inc., Yakira Capital Management, Inc., BERKLEY W R CORP, AQR Arbitrage LLC, Walleye Capital LLC, Walleye Trading LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 12 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.